SunTrust Robinson Humphrey lowered its price target on Galmed Pharmaceuticals (NASDAQ: GLMD) to $15.00 (from $19.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

H.C. Wainwright Remains Bullish on Galmed Pharma (GLMD) Followng Sell Off February 15, 2018 8:58 AM Pre-Open Movers 02/14: (FOSL) (IPCC) (CMG) Higher; (TTPH) (GLMD) (PIRS) Lower (more...)February 14, 2018 9:32 AM Maxim Group Downgrades Galmed Pharmaceuticals (GLMD) to HoldFebruary 14, 2018 9:06 AM Galmed Pharma (GLMD) Says ARRIVE Trial Did Not Meet its Primary Endpoint February 14, 2018 7:18 AM